Programme Members

Programme Contacts

University of Cambridge
Cancer Research UK Cambridge Institute
Programme Lead
University of Cambridge
Cancer Research UK Cambridge Institute
Programme Lead
University of Cambridge
Cancer Research UK Cambridge Institute
Programme Manager
  • All members
  • Group leaders
  • Clinical consultants
Cambridge University Hospitals NHS Foundation Trust
MRC Cancer Unit
Hutchison MRC Research Centre
I am a senior clinical oncology trainee currently undertaking a Clinical PhD Fellowship at the MRC Cancer Unit in Prof Ashok Venkitaraman's...
PI:
N
CC:
N
University of Cambridge
Cancer Research UK Cambridge Institute
CRUK Cambridge Institute
PI:
N
CC:
N
Cambridge University Hospitals NHS Foundation Trust
Department of Surgery
Hutchison MRC Research Centre
PI:
N
CC:
Y
University of Cambridge, Cambridge University Hospitals NHS Foundation Trust
Department of Oncology
Honorary Consultant Medical Oncologist
My research focus is in drug development and I translate preclinical findings on lead candidate agents into early phase clinical trials of...
PI:
Y
CC:
Y
University of Cambridge
Cancer Research UK Cambridge Institute
CRUK Cambridge Institute
PI:
Y
CC:
N
Cambridge University Hospitals NHS Foundation Trust
Department of Pathology
Pancreatic Cancer Centre
Undertaking collaborative research and trial support for pancreaticobiliary carcinoma.
PI:
Y
CC:
Y
Cambridge University Hospitals NHS Foundation Trust, University of Cambridge
Cancer Research UK Cambridge Institute, Department of Oncology
CRUK Cambridge Institute
Cambridge University Hospitals, NHS Foundation Trust
PI:
N
CC:
N
Cambridge University Hospitals NHS Foundation Trust
Not applicable/other
(tbc)
PI:
N
CC:
N
University of Cambridge
Department of Biochemistry
CRUK Cambridge Institute
PI:
N
CC:
N
Cambridge University Hospitals NHS Foundation Trust
Department of Radiology
.
PI:
N
CC:
Y
Cambridge University Hospitals NHS Foundation Trust, University of Cambridge
Department of Clinical Biochemistry
Wellcome MRC Institute of Metabolic Science
Hon Consultant Physician
PI:
Y
CC:
Y
Cambridge University Hospitals NHS Foundation Trust
Department of Oncology
Pancreatic cancer and immunotherapy
PI:
N
CC:
N
Cambridge University Hospitals NHS Foundation Trust
Department of Oncology
My research is based on improving outcomes for patients with chemoresistant cancers. I am chief investigator of the national adjuvant...
PI:
Y
CC:
Y
University of Cambridge
Cancer Research UK Cambridge Institute
CRUK Cambridge Institute
PI:
N
CC:
N
University of Cambridge
Department of Oncology
Hutchison MRC Research Centre
Discovery and development of small molecule inhibitors of protein-protein interactions as cancer therapeutics.
PI:
N
CC:
University of Cambridge
MRC Cancer Unit
Hutchison MRC Research Centre
- Biochemical Imaging - Mitosis, Genomic Instability - Optogenetics
PI:
N
CC:
CRUK Therapeutic Discovery Laboratories
Cancer Research UK Cambridge Institute
Wellcome Trust MRC Cambridge Stem Cell Institute
PI:
N
CC:
N
Cambridge University Hospitals NHS Foundation Trust
Not applicable/other
.
PI:
N
CC:
Y
University of Cambridge, Cambridge University Hospitals NHS Foundation Trust
Cancer Research UK Cambridge Institute, Department of Oncology
CRUK Cambridge Institute
PI:
N
CC:
N
University of Cambridge
Cancer Research UK Cambridge Institute
CRUK Cambridge Institute
PI:
Y
CC:
N
Cambridge University Hospitals NHS Foundation Trust
Not applicable/other
Pancreatic Cancer Centre
He qualified at Bristol University, and after completing house officer posts at the Bristol Royal Infirmary, worked at Bristol University...
PI:
N
CC:
Y
Cambridge University Hospitals NHS Foundation Trust, University of Cambridge
Department of Oncology
PI:
N
CC:
N
Cambridge University Hospitals NHS Foundation Trust
Not applicable/other
Pancreatic Cancer Centre
Asif Jah works at Cambridge University Hospital as a consultant surgeon in hepato-pancreatico-biliary (HPB) and transplant surgery. After...
PI:
N
CC:
Y
University of Cambridge
Department of Oncology
CRUK Cambridge Institute
Research of the host response in cancer, in particular cancer cachexia and anti-cancer immunity. Translational research, including clinical...
PI:
N
CC:
N
University of Cambridge
Cancer Research UK Cambridge Institute
Cambridge University Hospitals
I endeavour to integrate and optimise the pre-clinical development and science-led clinical application of novel therapies and novel...
PI:
Y
CC:
Y
University of Cambridge
Cancer Research UK Cambridge Institute
CRUK Cambridge Institute
PI:
Y
CC:
N
MRC Laboratory of Molecular Biology
Not applicable/other
PI:
N
CC:
N
University of Cambridge
Cancer Research UK Cambridge Institute
CRUK Cambridge Institute
PI:
N
CC:
N
Cambridge University Hospitals NHS Foundation Trust
Not applicable/other
Pancreatic Cancer Centre
Siong-Seng Liau is an MRC and Academy of Medical Sciences Tenure-track Clinician Scientist with a concurrent post as a Consultant...
PI:
Y
CC:
Y
University of Cambridge
Cancer Research UK Cambridge Institute
CRUK Cambridge Institute
PI:
N
CC:
N
(tbc)
PI:
N
CC:
N
AstraZeneca
Not applicable/other
A subset of tumoural cells, which is identified by expression of Fibroblast Activation Protein alpha (FAP), possess immunosuppressive...
PI:
N
CC:
N
University of Cambridge
Cancer Research UK Cambridge Institute
CRUK Cambridge Institute
PI:
N
CC:
N
Cambridge University Hospitals NHS Foundation Trust
(tbc)
PI:
N
CC:
N
University of Cambridge
Cancer Research UK Cambridge Institute
My group works within cancer systems biology and uses experimental and computational approaches to characterise cell signalling and cell-...
PI:
Y
CC:
N
MRC Laboratory of Molecular Biology
MRC Cancer Unit
Hutchison MRC Research Centre
PI:
N
CC:
N
University of Cambridge
Not applicable/other
sir stephen o'rahilly
PI:
Y
CC:
Y
University of Cambridge
Hutchison MRC Research Centre, MRC Cancer Unit
Hutchison MRC Research Centre
PI:
N
CC:
N
University of Cambridge
MRC Cancer Unit
My research tackles basic aspects of cell cycle control (particularly during mitosis) and genome stability in the context of tumour...
PI:
N
CC:
N
Cambridge University Hospitals NHS Foundation Trust
Department of Oncology
Human cancer develops as a localized focus of uncontrolled cell growth and subsequently progresses into systemic disease. Cancer research...
PI:
N
CC:
N
Cambridge University Hospitals NHS Foundation Trust
Not applicable/other
Pancreatic Cancer Centre
Raaj Praseedom is a Consultant HepatoPancreatoBiliary...
PI:
N
CC:
Y
University of Cambridge, Wellcome Trust Sanger Institute, Cambridge University Hospitals NHS Foundation Trust
Not applicable/other
University of Cambridge Clinical School
PI:
N
CC:
N
University of Cambridge
Cancer Research UK Cambridge Institute
PI:
Y
CC:
N
University of Cambridge
Cancer Research UK Cambridge Institute
CRUK Cambridge Institute
PI:
N
CC:
N
University of Cambridge
MRC Cancer Unit
Hutchison MRC Research Centre
PI:
N
CC:
N
University of Cambridge
Cancer Research UK Cambridge Institute
I am the Lab Head of the Cancer Research UK Pharmacology...
PI:
N
CC:
University of Cambridge
Department of Genetics
CRUK Cambridge Institute
Consequences of centrosome amplification in p53 null and Kras positive pancreatic organoids
PI:
N
CC:
N
Cambridge University Hospitals NHS Foundation Trust, University of Cambridge
Cancer Research UK Cambridge Institute, Department of Surgery
CRUK Cambridge Institute
PI:
N
CC:
N
University of Cambridge
Cancer Research UK Cambridge Institute
CRUK Cambridge Institute
PI:
N
CC:
N
University of Cambridge
Department of Biochemistry
The role of Myc in pancreatic cancer and the tumor microenvironment
PI:
N
CC:
N
University of Cambridge
Department of Pharmacology
PI:
Y
CC:
N
University of Cambridge
Cancer Research UK Cambridge Institute
CRUK Cambridge Institute
PI:
N
CC:
N
University of Cambridge
Department of Medicine
Fundamental adaptive immune mechanisms and their relationship to immunological and neoplastic human disease.
PI:
N
CC:
Y
University of Cambridge
MRC Cancer Unit
Hutchison MRC Research Centre
Human cancer cells almost always contain abnormal chromosomes, yet the connections between chromosomal instability and carcinogenesis are...
PI:
Y
CC:
N
AstraZeneca
Not applicable/other
(tbc)
PI:
N
CC:
N
University of Cambridge
Cancer Research UK Cambridge Institute
CRUK Cambridge Institute
PI:
Y
CC:
N
University of Cambridge
Cancer Research UK Cambridge Institute
CRUK Cambridge Institute
PI:
N
CC:
N